Biomerica (BMRA) Net Equity Issued and Repurchased (2018 - 2026)
Biomerica (BMRA) posted Net Equity Issued and Repurchased of $63000.0 for Q1 2026, down 87.22% sequentially from $493000.0 in Q4 2025, and down 96.4% YoY from $1.8 million in Q1 2025.
Biomerica (BMRA) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
Biomerica has reported Net Equity Issued and Repurchased for 8 years, with the latest figure at $63000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 96.4% year-over-year to $63000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.5 million (down 21.36% YoY) and the FY2025 annual result came in at $2.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased fell to $63000.0 in Q1 2026 per BMRA's latest filing, from $493000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $1.8 million in Q3 2022 and troughed at -$53000.0 in Q2 2023.
- A 4-year average of $584126.6 and a median of $309500.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
- The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased surged 116.02% in 2022, then plunged 20024.81% in 2023.
- Over 4 years, Net Equity Issued and Repurchased stood at $126000.0 in 2022, then plunged by 142.06% to -$53000.0 in 2023, then soared by 1030.19% to $493000.0 in 2025, then slumped by 87.22% to $63000.0 in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $63000.0, $493000.0, and $939000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 63,000.00 |
| Feb 28, 2026 | 63,000.00 |
| Nov 30, 2025 | 493,000.00 |
| Nov 30, 2025 | 493,000.00 |
| Aug 31, 2025 | 939,000.00 |
| Aug 31, 2025 | 939,000.00 |
| Feb 28, 2025 | 1.75 Mn |
| Feb 28, 2025 | 1.75 Mn |
| May 31, 2023 | -53,000.00 |
| May 31, 2023 | -53,000.00 |
| Feb 28, 2023 | 77,000.00 |
| Feb 28, 2023 | 77,000.00 |
| Nov 30, 2022 | 126,000.00 |
| Nov 30, 2022 | 126,000.00 |
| Aug 31, 2022 | 1.81 Mn |
| Aug 31, 2022 | 1.81 Mn |
| May 31, 2022 | 266.00 |
| May 31, 2022 | 266.00 |
| Feb 28, 2022 | 634,000.00 |
| Feb 28, 2022 | 634,000.00 |